Trial Profile
Randomised double-blind placebo-controlled trial of 40 mg/day of atorvastatin on reduction in severity of sepsis in ward patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2013
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Sepsis
- Focus Pharmacodynamics
- Acronyms ASEPSIS
- 21 Apr 2007 New trial record.